Next Generation Probiotics: The Development of Microbial-based Oral Formulations for Microbiome-altering Applications

Horniblow, Richard (Principal Investigator)

Biomedical Sciences

Short title	Next Generation Probiotics: The Development of Microbial-based Oral Formulations for Microbiome-altering Applications
Status	Finished
Effective start/end date	26/04/21 → 31/01/24

Funding

Engineering & Physical Science Research Council

1 Article

Novel pectin-carboxymethylcellulose-based double-layered mucin/chitosan microcomposites successfully protect the next-generation probiotic Akkermansia muciniphila through simulated gastrointestinal transit and alter microbial communities within colonic ex vivo bioreactors
Ta, L. P., Corrigan, S. & Horniblow, R., 15 Nov 2024, In: International Journal of Pharmaceutics. 665, 16 p., 124670.
Research output: Contribution to journal › Article › peer-review

Open Access
File
91 Downloads (Pure)